Loading company
CollPlant Biotechnologies Ltd
CLGN · Nasdaq · ·
Next earnings: September 30, 2026
$3.92+2.1%Sep 29 close
- 1M
- +9.5%
- 6M
- -33.6%
- 1Y
- -85.4%
- 5Y
- -97.6%
CLGN · Nasdaq · ·
Next earnings: September 30, 2026
$3.92+2.1%Sep 29 close
CollPlant Biotechnologies Ltd is scheduled to report next on September 30, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2025, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2025 | 3 months toJun 30, 2021 | Change |
|---|---|---|---|
| Total Revenue | $179K | $691K | -74.10% |
| Profit | -$3.3M | -$3M | -10.17% |
| Profit per share | -$0.28 | -$0.30 | +5.77% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
CollPlant Biotechnologies Ltd has no earnings call transcript available.
“In the first quarter of 2026, we initiated discussions with several leading strategic players to explore potential collaborations, primarily in the medical aesthetics field,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
CollPlant is a regenerative and aesthetic medicine company ushering in a new era of medical solutions with a focus on 3D bioprinting of tissues and organs, tissue repair and medical aesthetics. The Company’s products are based on its rhCollagen (recombinant human collagen) produced with CollPlant’s proprietary plant-based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from the 6-K CollPlant Biotechnologies Ltd filed on May 29, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.